Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547886 | SCV000646195 | likely benign | Multiple endocrine neoplasia type 4 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000567439 | SCV000673219 | benign | Hereditary cancer-predisposing syndrome | 2022-10-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000567439 | SCV002535471 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-18 | criteria provided, single submitter | curation | |
Gene |
RCV003151786 | SCV003840445 | uncertain significance | not provided | 2023-10-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003935474 | SCV004760404 | likely benign | CDKN1B-related disorder | 2022-03-22 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |